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Objectives: The aim of this study was to investigate the secretion of prostacyclin (PGIz), tissue plasminogen activator 
(tPA) and plasminogen activator inhibitor type 1 (PAl- 1) produced by human great saphenous vein endothelial cells 
(HSVECs) in vitro when seeded to confluency on different matrices. 
Methods: The matrices compared were: uncoated plastic, gelatin, collagen type-I gel, fibronectin, fibrin glue, de- 
endothelialised porcine aorta and ePTFE vascular grafts pre-coated with collagen type-I or human serum. 
Results: There were no significant differences between basal production of PGI z on the different matrices. The HSVECs 
responded with a significant increase in PGI2 secretion after stimulation with thrombin on all matrices, including the 
ePTFE grafts. A statistically significant higher secretion of tPA secretion was found in supernatants from cells cultured on 
collagen type-I gel. Interestingly, tPA secretion was lower by cells seeded on both collagen type-I and serum precoated 
ePTFE as compared to collagen type-1 gel. PAI-1 secretion however was significantly higher on collagen type-1 gel, gelatin, 
fibrin glue and porcine aorta but not on pre-coated ePTFE grafts. 
Conclusions: The findings emphasise the important effect of the matrix on endothelial secretion of PGI~ tPA and PAI-1. 
Differences in patency after implantation of in vitro endothelialised grafts, may be due to cellular function depending on 
the types of graft and matrix chosen. 
Key Words: Prostacyclin; Plasminogen activator inhibitor; Plasminogen activator; Human endothelial cells; Matrices; 
Vascular grafts. 
Introduction 
The vascular endothelium is a complex modulator of a 
variety of biological systems. It provides an inner 
lining of the blood vessels and has a crucial role in 
hemostasis, vascular tone, inflammation and angioge- 
nesis. ECs produce among other substances: prostacy- 
clin (PGI2), tissue plasminogen activator (tPA), its 
inhibitor PAI-1, thrombomodulin (TM) and protein C, 
all factors being of great importance in the main- 
tenance of blood fluidity. PGI2 is a short-acting 
powerful vasodilator and plays a very important role 
in the negative control of platelet aggregation espe- 
cially in situations in which platelet reactivity might 
be enhanced ue to local tissue damage. L2 
Thrombin has been reported to effect he synthesis, 
release or activation of a variety of plasma compo- 
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nents through its interaction with the vascular endo- 
thelium. 3'4 It proteolytically converts fibrinogen into 
fibrin and in the process binds the platelets to each 
other and to the vessel wall. Thrombin has previously 
been shown to stimulate PGI 2 production in several 
cultured human cell types, e.g. umbilical cord and 
great saphenous vein endothelial cells (HUVECs, 
HSVECs). 1'5-7 
tPA is the most important factor in the activation of 
the fibrinolytic system by conversion of plasminogen 
to plasmin, which in turn converts fibrin to soluble 
degradation products. Impaired fibrinolytic function 
caused by elevated plasma PAI-1 is the most com- 
monly observed isturbance in patients with throm- 
botic diseases, both venous and arterial, s 
Other endothelial-dependent mechanisms that pos- 
sibly regulate the fibrinolytic pathway are the activa- 
tion of protein C 9 and the thrombin-induced decline of 
intracellular plasminogen activator activity and 
release as described for bovine aortic endothelial cells 
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in culture. 3Rapid activation of protein C occurs when 
thrombin binds to an endothelial surface receptor, z°
Thrombin and TM form a complex which activates 
protein C, which in the presence of protein S bound to 
the endothelial surface, inactivates factor Va and VIIIa 
(vWF). 1~,~2 
A feature that uniquely distinguishes natural blood 
vessels from their artificial counterparts i the pres- 
ence of an endothelial cell lining. Creating a non- 
thrombogenic surface on prosthetic materials is a 
major challenge. Earlier clinical studies with intra- 
operatively recruited and low-density seeded ECs did 
not significantly improve the graft performanceY 
Recent studies have shown that cultured adult 
HSVECs can be used for endothelialisation of syn- 
thetic vascular grafts as well as biological and 
mechanical heart-valves. 6"~4-~6 Preoperative in vitro- 
endothelialisation human blood derived fibrin glue 
on ePTFE, is the only method evaluated in 
humans. 17'18 For any investigation concerning EC- 
function in vitro or where the outcome is dependent on 
the anti-thrombotic or fibrinolytic activity of ECs, the 
choice of matrix for attachment may be crucial. 
Although one obvious aim of seeding ECs onto 
cardiovascular prostheses is to prevent thrombus 
formation, little is known about EC-function after 
attachment to prosthetic materials. 
In this studN ELISA techniques were employed to 
compare the PGI2-, tPA-antigen- (tPA:ag) and PAI-1 
release by adult HSVECs seeded on different matrices 
commonly used for in vitro experiments or for attach- 
ment to cardiovascular prostheses. This included de- 
endothelialised porcine aorta and vascular expanded 
polytetrafluorethylene (ePTFE) grafts. Special empha- 
sis was put on the comparison between collagen type-I 
and human serum coated ePTFE grafts. 15"19 PGI T 
production was also investigated after thrombin 
stimulation. 
Material and Methods 
Isolation, cultivation and characterisation f endothelial 
cells 
ECs from 3-5 cm long, residual segments of the great 
saphenous vein received from patients undergoing 
coronary bypass surgery, were isolated and cultured 
as described previously. 6 BrieflN the veins were rinsed 
with Minimal Essential Medium (MEM, Gibco, Scot- 
land) and filled with a collagenase solution (0.1%, 
Worthington, Freehold, NJ, U.S.A.) in MEM and 
incubated for 20 min at 37°C. Harvested cells were 
centrifugated at800 g and then resuspended in culture 
medium containing MEM with the addition of 40% 
pooled heat-inactivated (56°C, 30 min) human serum 
(HS), cholera toxin (CT, 1 nM), isobutylmethylxantine 
(IBMX, 33/xM) and antibiotics (penicillin 50 × 103 
U/1 and streptomycin 50 rag/l). The cells were plated 
in gelatin-coated (0.5 ml, 0.2% gelatin in PBS incu- 
bated for 30 min at 4°C) wells (24 well plate, Costar, 
MA, U.S.A.). Cells were passaged (split ratio 1:3) using 
trypsin/EDTA (0.05/0.01% in PBS). The ECs were 
characterised asendothelial using immunohistochem- 
ical staining of von Willebrand factor related antigen 
and through their typical cobblestone appearance on 
microscopy. 6 For experiments, cells from the 4-6th 
passage were used. The endothelial cells were seeded 
in MEM containing only 30% human serum and 
antibiotics and thus cultured in the absence of CT and 
IBMX 48 h prior to the experiment. 
Preparation of matrices 
Gelatin: As described above for routine culture. 
Excess solution was removed before seeding. 
Collagen type-I gel: The method used by Montesano 
et al. 2° was used with minor modifications. Briefly, the 
collagen (Rat tail Boehringer Mannheim, GmbH, 
Germany) was dissolved in 0.2 M, mixed with MEM 
(10 × ), buffered with HEPES (Gibco, Scotland) and 
NaHCO3 to a final collagen concentration of 1.8 g/1. 
pH was adjusted with NaOH. To each well  0.3 ml was 
added and the collagen was allowed to solidify at 
37°C for 30 min. 
Fibronectin: Purified human fibronectin (Boehringer 
Mannheim) was used. The lyophilisate was dissolved 
in sterile water to a concentration of 1 mg/ml. 
Aliquots were diluted in MEM to a final concentration 
of 50 rag/1. 5/xg/cm 2was pipetted to each well and 
incubated for 45 min at room temperature. The excess 
solution was carefully removed before cell seeding. 
Fibrin glue: A gel was made using Tissucol due S, 
thrombin (Once®) and kleberproteinl6sung Zu 
(ERSTA®) which were mixed 1:1 according to the 
manufacturers instructions. A gel was formed 
immediately. 
Cells seeded on uncoated plastic wells were used as 
controls. On the above mentioned matrices, HSVECs 
were seeded at a density corresponding to 100000 
cells/cm 2.
Preparation of ePTFE vascular graft surfaces 
Serum precoating 
ePTFE (W.L. Gore and Associates, Flagstaff, AZ, 
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U.S.A.) grafts with the inner diameter of 8 mm were 
used. 15-20 ml (1.0-1.3 ml/cm 2 graft inner surface) 
pooled heat-inactivated HS was pressed through the 
graft wall as described previously, 19 emptied and left 
to dry at room temperature for 45 rain. The grafts were 
filled with a cell suspension corresponding to 200 000 
cells/cm 2 and were rotated stepwise as previously 
described. 15To allow complete ndothelialisation a d 
good adherence, seeded grafts were kept for two days 
under culture conditions in medium containing 30% 
pooled human serum and antibiotics before experi- 
ments. The grafts were then carefully cut into 0.5 cm 
circular pieces with a scalpel blade and put into 
culture wells as above. 
Collagen type-I precoating 
Collagen I (rat tail Boeringer Mannheim) was dis- 
solved in 10 ml sterile HAc (1 M) to a concentration of
3 g/1 and mixed with D-MEM (Dulbecco's-Modified 
Eagle's Medium, Gibco) 1:1 at 20°C. To allow the 
collagen to solidify, the pH was increased to 7.5-8 by 
the addition of 1M NaOH. A volume corresponding to
0.3 ml/cm ~ graft inner surface was pressed through 
the graft wall as previously described. 19 The graft was 
allowed to dry for 45 min at room temperature. Cells 
were seeded as described for serum precoated grafts. 
Preparation of porcine aorta 
Porcine aorta pieces were mechanically de-endotheli- 
alised using a scalpel blade followed by devitalisation 
and storage in sterile de-ionised water containing 
antibiotics until seeding. 21 Before seeding, the porcine 
aorta was allowed to soak in culture media for 2h and 
then cut into pieces measuring approximately 1 cm 2. 
Cells were seeded at a density corresponding to 
200 000 cells/cm 2. 
Prostacyclin assay 
Unstimulated cultures on the respective matrices or 
grafts were compared to thrombin-stimulated cultures 
(0.5 U/ml  in MEM, Sigma Chemical Co, St. Louis, 
MO, U.S.A.) for 30 min at 37°C. The supernatants were 
collected and stored at -20 ° until analysis. PGI2 
concentrations were assayed using enzyme-linked 
immunosorbent assay- (ELISA) kits of its stable 
metabolite 6-keto prostaglandin-Flc~ (Cayman Chem- 
ical Co, MI, U.S.A.). 
t PA:a g/PAI- l-assays 
Following the experiments for detection of prostacy- 
din production as described above, 1-2 ml MEM with 
the addition of 2% HS was added to the wells and 
maintained for 24 h at 37°C. The supernatants were 
collected and analysed for tPA:ag and PAI-1 using 
ELISA techniques (Biopool TintElize TM tPA and Bio- 
pool Imulyse TM PAI-1) according to the manufacturers 
instructions. 
Determination of cell numbers 
Previous investigations have shown that the inocu- 
lated number of cells should be as described above to 
achieve immediate confluency and to achieve asimilar 
cell density. The HSVECs on the different matrices and 
grafts were fixed and stained using crystal violet (0.1% 
in 20% ethanol) for 10 min and allowed to dry for 
6-12h at room temperature before examination. There 
was minimal shrinkage of ePTFE as well as porcine 
aorta after this period. The cultures and surfaces of the 
grafts were examined in a Nikon microphot inverted 
microscope or a Leica fluovert Fu microscope. The 
ePTFE-rings were cut open prior to staining. The cell 
number/cm 2 was determined on video printouts and 
micrographs, including scale bars, in areas of 100 × 
100 ~m at four randomly selected places on each 
matrix and graft type for each experiment. 
Statistical analysis 
Data obtained from cells on different matrices were 
comparable within each experiment due to the facts 
that the cells used were derived from the same patient, 
were in the same passage and the number of cells/cm 2
were calculated and differences were compensated for. 
The mean of triplicate cultures on a single matrix in 
each experiment was used as a single data point in a 
paired, two-tailed Student's t-test. The number of 
experiments (n) for each matrix or pre-coated graft 
varied between 3-8 depending on accessability (pigs) 
and economical reasons (fibrin glue). 
Results 
PGI2, tPA:ag and PAI-1 
In media collected from cells cultured on uncoated 
plastic, the mean PGI2 concentration was 695 pg/105 
cells. When stimulated with thrombin a 2.5 fold 
increase in concentration was found. The basal (non- 
stimulated) levels of PGI 2 concentration was higher, 
but not statistically significant, in media collected 
from cells cultivated on fibrin glue (1800 pg/105 cells), 
porcine aorta (1600 pg/105 cells) and ePTFE coated 
with human serum (1650 pg/105 cells) (Fig. 1) as 
compared to cells grown on plastic and gelatin. The 
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cells responded with a significant increase in PGI2 
production as compared to their unstimulated coun- 
terparts, on all matrices investigated (Fig. 1). When 
stimulated with thrombin, the highest level of PGI 2 
was found in media collected from cells seeded on 
collagen precoated ePTFE grafts (3800 pg/105 cells) 
and collagen type I gel (3750 pg/105 cells) (Fig. 1). 
The mean concentration of tPA:ag in media from 
cells cultured on plastic was 0.50 ng/105 cells. The 
increase of tPA:ag concentration i media from cells 
cultured on collagen type-I gel was 4.7-, fibronectin 
1.9-, pig aorta 1.9-, gelatin 1.8- and on fibrin glue 1.5- 
fold. In media collected from cells seeded on collagen 
type-I or human serum precoated ePTFE grafts, the 
concentrations of tPA were 0.47 ng/10 s cells and 0.58 
ng/10 s cells respectively (Fig. 2). 
The mean PAI-1 concentration in supernatants from 
cells cultured on plastic was 90 ng/105 cells. The 
increase of PAI-1 concentration i media from cells 
cultured on fibrin glue was 2.2-, pig aorta 2.1-, 
collagen type-I 1.9-, fibronectin 1.5- and on gelatin 1.4- 
fold (Fig. 3). The mean PAI-1 levels in media collected 
from cells cultured on collagen type-I and serum 
precoated ePTFE grafts were 80 ng/105 cells and 64 
ng/105 cells respectively (Fig. 3). 
Discussion 
Recent techniques for culture of human endothelial 
cells allow studies that reflect the function of the 
human endothelium. It is of obvious importance if
vascular ECs exhibit an altered antithrombotic o r  
thrombolytic apacity depending on their origin, 
culture technique or the subendothelial matrix the 
cells are cultured on. In this study, differences in the 
secretion of PGI 2, tPA:ag and PAI by HSVECs were 
observed 2 days after seeding onto the underlying 
matrix. The culture technique used in this study is an 
alternative to media containing heparin and endothe- 
lial cell growth factor. We omitted the cyclic AMP- 
elevating factors 2 days prior to the experiments o
avoid a cAMP-induced effect at the time of experi- 
ments. Different results due to culture techniques 
cannot be ruled out. Interestingly, heparin and ECGS 
have been shown to supress prostacyclin produc- 
tion. 22 While HSVECs on uncoated plastic and the 
commonly used gelatin precoating revealed a lower 
basal prostacyctin secretion, the cells on all matrices 
responded with a large increase in PGI2 production 
upon thrombin stimulation. This indicates that the 
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Fig. 1. Scattergram showing the distribution and mean PGI2 release from cultured human saphenous endothelial cells (HSVECs) seeded on 
different matrices. No significant differences were seen in basal secretion. Significant increases were observed on all matrices after thrombin 
stimulation, p-values are as compared to basal secretion on the respective matrix. Mean values are denoted by (-). 
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under all circumstances employed. The highest pro- 
duction of PGI 2 was noted by stimulated cells seeded 
on collagen type-I, precoated ePTFE grafts and por- 
cine aorta. However, there was a variation found in 
the levels of PGI 2 production between the individual 
donors which is in accordance to previous studies. 6'7 
The 2 to 3-fold increase of PGI 2 production after 
thrombin stimulation is also similar to previous results 
obtained on HSVECs in the absence of exogenous 
arachidonate. 7 
The tPA:ag levels produced by HSVECs seeded on 
collagen type-I were significantly higher, compared to 
other matrices investigated. To our knowledge, it has 
not previously described that collagen type-I influ- 
ences the tPA production of HSVECs. Other inves- 
tigators 7 have shown that prostacyclin and t-PA:ag 
secretion from HSVECs are larger from cells seeded on 
fibronectin- vs .  uncoated ePTFE. However, the data 
are not comparable to the data presented in this study 
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Fig. 2. Scattergram showing the distribution and mean t-PA:ag secretion from cultured HSVECs seeded on different matrices. The t-PA:ag 
secretion from HSVECs cultured on collagen type-I was significantly higher compared to the matrices examined with the exception of 
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Fig. 3. Scattergram showing the distribution and mean plasminogen activator inhibitor-1 (PAI-1) release from HSVECs seeded on different 
matrices. Cells seeded on gelatin, collagen type-1 gel, fibrin glue and porcine aorta were significantly higher, p-values are analysed in 
comparison to HSVECs seeded on uncoated plastic. Mean values are denoted by (-). 
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relatively high levels of PAI-1 and low levels of tPA 
during culture may well be induced by the presence of 
TGFG1 in serum, z3'24 and therefore the choice of 
serum can also give somewhat different results 
between different investigators. 
Since we are at present using serum pre-coated 
ePTFE grafts for endothelialisation clinically, we chal- 
lenged the serum coating technique with collagen 
type-I coated grafts. It was shown that PAI-1 secretion 
by cells seeded on ePTFE, irrespective of the coating, 
tended to be lower than on the different matrices 
tested in culture wells as well as on porcine aorta. The 
only significant difference in t-PA secretion was 
obtained in comparison to collagen type-1 gel. This 
could be explained by the close relation to ePTFE 
which partly limits tPA/PAI-1 expression or secretion. 
Another possibility is that PAI-1, and tPA may be 
immobilised on ePTFE. It is difficult to determine the 
actual collagen fibre density on ePTFE at the time of 
seeding as compared to the collagen gel formed in the 
wells. The differences in tPA secretion may be 
explained by the fact that the collagen fibre density 
influences the EC function. The attachment of 
HSVECs to serum-pre-coated PTFE is dependent on 
a certain amount of serum being pressed through the 
graft wall 15'19 and the serum pre-coating technique is 
therefore not applicable in culture wells and direct 
comparisons cannot be made. 
The tPA:ag levels described in this study are lower 
than the tPA:ag secretion by HUVECs seeded on 
uncoated plastic of 2.17 ng/10 scells/24h described by 
Wojta et al. 2~ It must be remembered that the cells used 
in our study were derived from patients with athero- 
sclerosis requiring a coronary bypass operation. The 
donor cells may have exhibited abnormal func- 
tions. 26"27 However, these patients are typical recipi- 
ents of an endothelialised graft. The accessibility of 
normal HSVECs is a limitation for making compar- 
ative studies. 
Endothelial cell seeding of synthetic and biological 
grafts have been promoted as a method of improving 
patency and durability of e.g. heart valves. 14'21 Fibrin 
glue has been used as a matrix for seeding of HSVECs 
on vascular ePTFE grafts, z8 Interestingly, the addition 
of the protease inhibitor aprotinin has then been 
necessary to prevent cellular detachment ~8'29 due to 
EC-plasminogen activit3a Fibrin glue is currently not 
approved by the U.S. Food and Drug Administration 
and other clinically applicable matrices have been 
sought. Serum precoating appears to be a safe and 
simple method to achieve a confluent and flow 
resistant endothelium on ePTFE. ~s Our preliminary 
data in a clinical study suggest that an antithrombotic 
function is maintained by ECs seeded on serum pre- 
coated ePTFE. 
In conclusion, the choice of matrix affects the 
amount of PGIz, tPA:ag and PAI-1 secreted. Collagen 
type-I gel was shown to be the superior matrix in 
terms of high tPA production. Although prostacyclh~ 
secretion on collagen type-I or serum coated ePTFE 
was comparable, secretions of tPA and PAI-1 were 
lower, indicating unique properties of human saphe- 
nous vein endothelial cells on ePTFE. This emphasises 
the importance of consistency when conducting and 
comparing in vitro experiments. It also suggests that 
when ECs are used for clinical purposes, the EC 
function may differ at the time of implantation 
depending on the type of prosthetic material and pre- 
coating chosen. 
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